SITO Mobile Launches Real-time In-store Attribution
Apr 14, 2016 12:00 pm UTC| Business
JERSEY CITY, N.J., April 14, 2016 -- SITO Mobile Ltd. (SITO) (NASDAQ:SITO), a leading mobile engagement platform provider, announced today the launch of Real-time Verified Walk-In (VWI), a proprietary technology that...
Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
Apr 14, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., April 14, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
Apr 14, 2016 12:00 pm UTC| Business
SB 9200 followed by entecavir resulted in significant declines in viral DNA, RNA and surface antigens in the woodchuck model of HBV; results support advancement of SB 9200 to Phase 2 in HBV SB 9200 inhibited the...
CCA Announces 2016 First Quarter Earnings Release and Conference Call Dates
Apr 14, 2016 12:00 pm UTC| Business
NASHVILLE, Tenn., April 14, 2016 -- CCA (NYSE:CXW) (the “Company” or “Corrections Corporation of America”), America's largest owner of partnership correctional, detention, and reentry facilities, announced today that it...
Unitil Schedules First Quarter 2016 Earnings Conference Call
Apr 14, 2016 11:50 am UTC| Business
HAMPTON, N.H., April 14, 2016 -- Unitil Corporation (NYSE:UTL) (www.unitil.com) will host a quarterly conference call to discuss first quarter 2016 financial results on Thursday, April 21, at 2:00 PM Eastern Time....
Micron Announces Proposed $1 Billion Offering of Senior Secured Notes
Apr 14, 2016 11:42 am UTC| Business
BOISE, Idaho, April 14, 2016 -- Micron Technology, Inc. (NASDAQ:MU) today announced that it intends to offer, subject to market and other considerations, $1 billion aggregate principal amount of senior secured notes due...
SteadyMed to Host an Analyst and Investor Reception
Apr 14, 2016 11:30 am UTC| Business
SAN RAMON, Calif., April 14, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a pre-NDA stage specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet...